Quest Diagnostics (DGX) PT Raised to $215 at Citi
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $235.52 +0.48%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Citi analyst Patrick Donnelly raised the price target on Quest Diagnostics (NYSE: DGX) to $215.00 (from $190.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- York Space Systems (YSS) PT Lowered to $15 at Jefferies
- Rocket Lab joins U.S. Space Force's $981M NITE-STAR contract
- BofA Securities Starts Definium Therapeutics Inc (DFTX) at Buy
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Citi, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
